A radiation oncologist is a cancer doctor with special training in using radiation therapy (RT) to treat cancer with radiation.
An early drug development specialist tests new drugs to treat cancer. They have special training in research studies, known as clinical trials.
Assistant Attending Radiation Oncologist
Areas of Expertise
Conditions I Treat
Spine tumors and spinal cancer
My Specialties
Intensity-modulated radiation therapy (IMRT)
Image-guided radiation therapy (IGRT)
Education & Honors
Education
MD, Johns Hopkins University School of Medicine
Residencies
Radiation Oncology - University of North Carolina Hospitals
Fellowships
Memorial Sloan Kettering Cancer Center
Board Certifications
Radiation Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
Aetna
In Network Coverage Type HMO, EPO PPO, POS, Transplant
Request an appointment by logging in to MSK MyChart or calling your Care Team. If you are not enrolled in MSK MyChart, ask your Care Team to send you an invitation. You can also go to MSK MyChart and select “Sign up now.”
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Visit PubMed for a full listing of Dr. Higginson’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
We strive to keep reviews trustworthy, honest and fair.
Learn more about our patient experience reviews.
4.940 reviews
4.9Provider's Explanations Easy to Understand
4.9Trusts Provider with Care
4.9Provider Listened Carefully
4.9Likelihood of Recommending Provider
Mar 24, 2025
I could not ask for more from the tele-health session. Highest marks right across the board.
Mar 24, 2025
Dr. Higginson is a very caring and informative doctor.
Feb 10, 2025
The Epic MyChart is a complete mess. It's so hard to do a couple of medicine, you gotta fill out all these forms every single time. It gets ridiculous. Like the MyChart is crazy. You guys got to fix the Epic install at your place. It's hard to use as a patient and it's very, very frustrating.
Aug 12, 2024
It's not just the provider. Everyone I come in contact with at Sloan is polite, thoughtful, and caring. Excellent overall experience!.
Aug 5, 2024
Exactly as the Radiation team explained the process was exactly how it happened. Can't thank your staff enough for the care and professionalism they gave me during these (3) treatments. Thank you to the MSK staff for all your care!!
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Daniel S. Higginson discloses the following relationships and financial interests:
AstraZeneca Professional Services and Activities (Uncompensated)
Natera Inc. Professional Services and Activities (Uncompensated)
SQZ Biotechnologies Company Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.